Proposal of membrane transport mechanism of protein-unbound ulifloxacin into epithelial lining fluid determined by improved microdialysis

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 9, 2008, Pages 1773-1777

  Aoki, Makoto ^a   Iguchi, Maki ^a   Hayashi, Hiroyuki ^a   Suzuki, Hisashi ^a   Shibasaki, Shigeki ^a   Kurosawa, Tohru ^a   Hayashi, Masahiro ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Epithelial lining fluid; Microdialysis method; Rat; Ulifloxacin; Urea

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; ULIFLOXACIN; UNCLASSIFIED DRUG; UREA;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG PENETRATION; EPITHELIAL LINING FLUID; IN VITRO STUDY; IN VIVO STUDY; LIQUID; LUNG LAVAGE; MALE; MEMBRANE TRANSPORT; MICRODIALYSIS; NONHUMAN; PERMEATION CLEARANCE; QUANTITATIVE ASSAY; RAT; STANDARD; TECHNIQUE;

ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIUM; FLUOROQUINOLONES; INJECTIONS, INTRAVENOUS; MALE; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; PERMEABILITY; PIPERAZINES; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; UREA;

EID: 51449090509     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1773     Document Type: Article

References (38)

1. Honeybourne D., Curr. Opin. Pulm. Med., 3, 170-174 (1997).
2. Cook P. J., Andrews J. M., Wise R., Honeybourne D., J. Antimicrob. Chemother., 37, 331-339 (1996).
3. Baldwin D. R., Honeybourne D., Wise R., Antimicrob. Agents Chemother., 36, 1171-1175 (1992).
4. Carcas A. J., Garcia-Satue J. L., Zapater P., Frias-Iniesta J., Clin. Pharmacol. Ther., 65, 245-250 (1999).
5. Muller-Serieys C., Soler P., Cantalloube C., Lemaitre F., Gia H. P., Brunner F., Andremont A., Antimicrob. Agents Chemother., 45, 3104-3108 (2001).
6. Allegranzi B., Cazzadori A., Di Perri G., Bonora S., Berti M., Franchino L., Biglino A., Cipriani A., Concia E., J. Antimicrob. Chemother., 46, 319-322 (2000).
7. Deguchi Y., Terasaki T., Yamada H., Tsuji A., J. Pharmacobiodyn., 15, 79-89 (1992).
8. Buerger C., Plock N., Dehghanyar P., Joukhadar C., Kloft C., Antimicrob. Agents Chemother., 50, 2455-2463 (2006).
9. Skhirtladze K., Hutschala D., Fleck T., Thalhammer F., Ehrlich M., Vukovich T., Muller M., Tschernko E. M., Antimicrob. Agents Chemother., 50, 1372-1375 (2006).
10. Eisenberg E. J., Conzentino P., Eickhoff W. M., Cundy K. C., J. Pharmacol. Toxicol. Methods, 29, 93-98 (1993).
11. Deguchi Y., Sun J., Tauchi Y., Sakai S., Morimoto K., Drug Metab. Pharmacokinet., 18, 319-326 (2003).
12. Deguchi Y., Terasaki T., Kawasaki S., Tsuji A., J. Pharmacobiodyn., 14, 483-492 (1991).
13. Okuyama Y., Momota K., Morino A., Arzneim.-Forsch., 47, 276-284 (1997).
14. Eisenberg E. J., Bidgood A., Cundy K. C., Antimicrob. Agents Chemother., 41, 1949-1952 (1997).
15. Capitano B., Potoski B. A., Husain S., Zhang S., Paterson D. L., Studer S. M., McCurry K. R., Venkataramanan R., Antimicrob. Agents Chemother., 50, 1878-1880 (2006).
16. Lamer C., de Beco V., Soler P., Calvat S., Fagon J. Y., Dombret M. C., Farinotti R., Chastre J., Gibert C., Antimicrob. Agents Chemother., 37, 281-286 (1993).
17. Taylor A. E., Guyton A. C., Bishop V. S., Circ. Res., 16, 353-362 (1965).
18. Theodore J., Robin E. D., Gaudio R., Acevedo J., Am. J. Physiol., 229, 989-996 (1975).
19. Adams F. H., Moss A. J., Fagan L., Biol. Neonat., 5, 151-158 (1963).
20. Cheng P. W., Boat T. F., Shaikh S., Wang O. L., Hu P. C., Costa D. L., Exp. Lung Res., 21, 351-365 (1995).
21. Tschumperlin D. J., Margulies S. S., J. Appl. Physiol., 86, 2026-2033 (1999).
22. Bastacky J., Lee C. Y., Goerke J., Koushafar H., Yager D., Kenaga L., Speed T. P., Chen Y., Clements J. A., J. Appl. Physiol., 79, 1615-1628 (1995).
23. Groneberg D. A., Nickolaus M., Springer J., Doring F., Daniel H., Fischer A., Am. J. Pathol., 158, 707-714 (2001).
24. Brechot J. M., Hurbain I., Fajac A., Daty N., Bernaudin J. F., J. Histochem. Cytochem., 46, 513-517 (1998).
25. Devaskar S. U., deMello D. E., J. Clin. Endocrinol. Metab., 81, 4373-4378 (1996).
26. Lechapt-Zalcman E., Hurbain I., Lacave R., Commo F., Urban T., Antoine M., Milleron B., Bernaudin J. F., Eur. Respir. J., 10, 1837-1843 (1997).
27. Tamai I., Yamashita J., Kido Y., Ohnari A., Sai Y., Shima Y., Naruhashi K., Koizumi S., Tsuji A., J. Pharmacol. Exp. Ther., 295, 146-152 (2000).
28. Niinuma K., Kato Y., Suzuki H., Tyson C. A., Weizer V., Dabbs J. E., Froehlich R., Green C. E., Sugiyama Y., Am. J. Physiol., 276, G1153-1164 (1999).
29. Sasabe H., Tsuji A., Sugiyama Y., J. Pharmacol. Exp. Ther., 284, 1033-1039 (1998).
30. Urakami Y., Akazawa M., Saito H., Okuda M., Inui K., J. Am. Soc. Nephrol., 13, 1703-1710 (2002).
31. Uwai Y., Okuda M., Takami K., Hashimoto Y., Inui K., FEBS Lett., 438, 321-324 (1998).
32. Zhao Y. L., Cai S. H., Wang L., Kitaichi K., Tatsumi Y., Nadai M., Yoshizumi H., Takagi K., Hasegawa T., Clin. Exp. Pharmacol. Physiol., 29, 167-172 (2002).
33. Naruhashi K., Tamai I., Inoue N., Muraoka H., Sai Y., Suzuki N., Tsuji A., J. Pharm. Pharmacol., 53, 699-709 (2001).
34. Sasabe H., Kato Y., Suzuki T., Itose M., Miyamoto G., Sugiyama Y., J. Pharmacol. Exp. Ther., 310, 648-655 (2004).
35. Suzuki T., Kato Y., Sasabe H., Itose M., Miyamoto G., Sugiyama Y., Drug Metab. Dispos., 30, 1393-1399 (2002).
36. Girard A. E., Cimochowski C. R., Faiella J. A., J. Antimicrob. Chemother., 37 (Suppl C), 9-19 (1996).
37. Soman A., Honeybourne D., Andrews J., Jevons G., Wise R., J. Antimicrob. Chemother., 44, 835-838 (1999).
38. Honeybourne D., Thorax, 49, 104-106 (1994).